文献速递神经肿瘤

质量结局数据库肿瘤登记处的启动:理由、开发与试点数据

Launching the Quality Outcomes Database Tumor Registry: rationale, development, and pilot data.
PubMed 文献 · J Neurosurg · 2021-08-06

美国AANS/CNS肿瘤分会提出并获QOD科学委员会批准,于2019年2月启动QOD肿瘤登记处,在8个学术中心开展为期1年的试点,评估纵向收集6类常见颅内肿瘤患者人口学、临床、手术及患者报告结局特征的可行性。

要点

  • QOD肿瘤登记处试点验证了纵向收集颅内肿瘤结局数据的可行性。
  • 登记覆盖6类常见颅内肿瘤,包括脑转移瘤、高级别胶质瘤、低级别胶质瘤、脑膜瘤、垂体瘤及其他颅内肿瘤。

核心结论

  • 作为试点研究,作者证明了纵向记录6种常见颅内肿瘤类型的人口学、临床、手术和患者报告结局特征的可行性。

研究设计与样本

  • QOD肿瘤登记处于2019年2月启动,初始1年试点阶段纳入8个中心。
  • 该登记处由AANS/CNS肿瘤分会提出,于2018年秋季获QOD科学委员会批准。
  • 试点阶段旨在评估从美国8个学术实践机构收集结局数据的可行性,结局包括住院时长、出院去向和住院并发症。

主要发现

  • 颅内转移瘤占17.3%(n=160),高级别胶质瘤占18.5%(n=171),低级别胶质瘤占6%(n=55),脑膜瘤占20%(n=184),垂体瘤占14.3%(n=132),其他颅内肿瘤占24%(n=221)。

临床怎么用

  • 该试点为神经外科肿瘤领域建立实时、可比的质量结局登记提供了可行性依据。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Neurosurgeons generate an enormous amount of data daily. Within these data lie rigorous, valid, and reproducible evidence. Such evidence can facilitate healthcare reform and improve quality of care. To measure the quality of care provided objectively, evaluating the safety and efficacy of clinical activities should occur in real time. Registries must be constructed and collected data analyzed with the precision akin to that of randomized clinical trials to accomplish this goal. METHODS: The Quality Outcomes Database (QOD) Tumor Registry was launched in February 2019 with 8 sites in its initial 1-year pilot phase. The Tumor Registry was proposed by the AANS/CNS Tumor Section and approved by the QOD Scientific Committee in the fall of 2018. The initial pilot phase aimed to assess the feasibility of collecting outcomes data from 8 academic practices across the United States; these outcomes included length of stay, discharge disposition, and inpatient complications. RESULTS: As of November 2019, 923 eligible patients have been entered, with the following subsets: intracranial metastasis (17.3%, n = 160), high-grade glioma (18.5%, n = 171), low-grade glioma (6%, n = 55), meningioma (20%, n = 184), pituitary tumor (14.3%, n = 132), and other intracranial tumor (24%, n = 221). CONCLUSIONS: The authors have demonstrated here, as a pilot study, the feasibility of documenting demographic, clinical, operative, and patient-reported outcome characteristics longitudinally for 6 common intracranial tumor types.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Asher AL, Khalafallah AM, Mukherjee D, et al. Launching the Quality Outcomes Database Tumor Registry: rationale, development, and pilot data. J Neurosurg. 2021. PMID: 34359037. doi:10.3171/2021.1.JNS201115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。